CERO
Price
$0.78
Change
+$0.08 (+11.43%)
Updated
Apr 9, 04:25 PM (EDT)
Capitalization
2.14M
KALV
Price
$10.78
Change
+$0.46 (+4.46%)
Updated
Apr 9, 04:43 PM (EDT)
Capitalization
513.07M
85 days until earnings call
Ad is loading...

CERO vs KALV

Header iconCERO vs KALV Comparison
Open Charts CERO vs KALVBanner chart's image
CERo Therapeutics Holdings
Price$0.78
Change+$0.08 (+11.43%)
Volume$1.19K
Capitalization2.14M
KalVista Pharmaceuticals
Price$10.78
Change+$0.46 (+4.46%)
Volume$1.4K
Capitalization513.07M
CERO vs KALV Comparison Chart
Loading...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CERO vs. KALV commentary
Apr 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CERO is a Hold and KALV is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 09, 2025
Stock price -- (CERO: $0.70 vs. KALV: $10.32)
Brand notoriety: CERO and KALV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CERO: 51% vs. KALV: 190%
Market capitalization -- CERO: $2.14M vs. KALV: $513.07M
CERO [@Biotechnology] is valued at $2.14M. KALV’s [@Biotechnology] market capitalization is $513.07M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.55B to $0. The average market capitalization across the [@Biotechnology] industry is $1.98B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CERO’s FA Score shows that 1 FA rating(s) are green whileKALV’s FA Score has 0 green FA rating(s).

  • CERO’s FA Score: 1 green, 4 red.
  • KALV’s FA Score: 0 green, 5 red.
According to our system of comparison, KALV is a better buy in the long-term than CERO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CERO’s TA Score shows that 3 TA indicator(s) are bullish while KALV’s TA Score has 4 bullish TA indicator(s).

  • CERO’s TA Score: 3 bullish, 2 bearish.
  • KALV’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CERO is a better buy in the short-term than KALV.

Price Growth

CERO (@Biotechnology) experienced а -2.08% price change this week, while KALV (@Biotechnology) price change was -7.49% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.87%. For the same industry, the average monthly price growth was -11.06%, and the average quarterly price growth was -15.27%.

Reported Earning Dates

CERO is expected to report earnings on Mar 24, 2023.

KALV is expected to report earnings on Jul 03, 2025.

Industries' Descriptions

@Biotechnology (-4.87% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KALV($513M) has a higher market cap than CERO($2.14M). KALV YTD gains are higher at: 21.842 vs. CERO (-88.250). KALV has more cash in the bank: 253M vs. CERO (3.38M). CERO has less debt than KALV: CERO (1.81M) vs KALV (5.78M).
CEROKALVCERO / KALV
Capitalization2.14M513M0%
EBITDAN/A-173.23M-
Gain YTD-88.25021.842-404%
P/E RatioN/AN/A-
RevenueN/A0-
Total Cash3.38M253M1%
Total Debt1.81M5.78M31%
FUNDAMENTALS RATINGS
KALV: Fundamental Ratings
KALV
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
57
Fair valued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
43
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CEROKALV
RSI
ODDS (%)
Bullish Trend 2 days ago
71%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
73%
Bearish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 21 days ago
50%
Bullish Trend 16 days ago
79%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 9 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Ad is loading...
CERO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KALV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY496.48-7.90
-1.57%
SPDR® S&P 500® ETF
GME23.39-0.90
-3.71%
GameStop Corp
BTC.X76271.950000-2963.382800
-3.74%
Bitcoin cryptocurrency
TSLA221.86-11.43
-4.90%
Tesla
AAPL172.42-9.04
-4.98%
Apple

CERO and

Correlation & Price change

A.I.dvisor tells us that CERO and IBIO have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CERO and IBIO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CERO
1D Price
Change %
CERO100%
-0.70%
IBIO - CERO
30%
Poorly correlated
N/A
BRTX - CERO
30%
Poorly correlated
+3.53%
KALV - CERO
27%
Poorly correlated
-10.26%
IMRN - CERO
26%
Poorly correlated
-0.58%
GOVX - CERO
24%
Poorly correlated
+1.89%
More

KALV and

Correlation & Price change

A.I.dvisor indicates that over the last year, KALV has been loosely correlated with ATXS. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if KALV jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KALV
1D Price
Change %
KALV100%
-10.26%
ATXS - KALV
46%
Loosely correlated
-16.67%
AVIR - KALV
44%
Loosely correlated
-4.68%
IDYA - KALV
42%
Loosely correlated
-4.23%
FATE - KALV
41%
Loosely correlated
-0.40%
RCKT - KALV
40%
Loosely correlated
-7.71%
More